Eam Investors, LLC Guardant Health, Inc. Transaction History

Eam Investors, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 13, 2019	SELL	$62.59 - $110.3 $938,599 - $1.65 Million	-14,996 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$63.94 - $91.11 $88,237 - $125,731	-1,380 Reduced 8.43%	14,996 $1.3 Million
Q1 2019 May 13, 2019	SELL	$34.3 - $97.98 $769,863 - $2.2 Million	-22,445 Reduced 57.82%	16,376 $1.26 Million
Q4 2018 Feb 13, 2019	BUY	$29.2 - $46.1 $1.13 Million - $1.79 Million	38,821 New	38,821 $1.46 Million

323

127M

844K

2.38M

Ticker GH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,220,000
Market Cap $3.23B
Description
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...

Get notified when there are updates to the investment portfolio of Eam Investors, LLC, based on Form 13F filings with the SEC.

Stay updated on Eam Investors, LLC with notifications on news.